Tilray Brands, Inc. (TLRY)
NASDAQ: TLRY · Real-Time Price · USD
1.560
+0.020 (1.30%)
At close: Oct 17, 2025, 4:00 PM EDT
1.570
+0.010 (0.63%)
After-hours: Oct 17, 2025, 7:59 PM EDT
Tilray Brands Revenue
Tilray Brands had revenue of $209.50M in the quarter ending August 31, 2025, with 4.73% growth. This brings the company's revenue in the last twelve months to $830.77M, up 2.31% year-over-year. In the fiscal year ending May 31, 2025, Tilray Brands had annual revenue of $821.31M with 4.10% growth.
Revenue (ttm)
$830.77M
Revenue Growth
+2.31%
P/S Ratio
1.76
Revenue / Employee
$292,317
Employees
2,842
Market Cap
1.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
May 31, 2025 | 821.31M | 32.37M | 4.10% |
May 31, 2024 | 788.94M | 161.82M | 25.80% |
May 31, 2023 | 627.12M | -1.25M | -0.20% |
May 31, 2022 | 628.37M | 115.29M | 22.47% |
May 31, 2021 | 513.09M | 107.76M | 26.59% |
May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
TLRY News
- 1 day ago - Tilray Brands Marks Seven Years of Cannabis Legalization in Canada with the #1 Market-Leading Position by Revenue and Pioneering Brands with Growing Market Share in the World's Largest Federally Legal Cannabis Market - GlobeNewsWire
- 3 days ago - Tilray Stock Rises As Study Links Medical Cannabis To Lower Opioid Use - Benzinga
- 5 days ago - Tilray Medical Announces Expansion Plans in Panama, Strengthening Global Cannabis Leadership and Accelerating International Growth - GlobeNewsWire
- 5 days ago - Tilray stock price forecast as a shooting star candle forms - Invezz
- 7 days ago - Top 3 Canadian Cannabis Stocks to Watch in October 2025 - MarijuanaStocks
- 8 days ago - Tilray Reports Strong Q1-2026 Earnings As The Cannabis Sector Rallies - Seeking Alpha
- 9 days ago - Tilray Brands, Inc. (TLRY) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 9 days ago - Tilray stock: why options data is skewed to downside despite solid Q1 earnings - Invezz